The bladder cancer market is poised for transformative growth between 2025 and 2035, driven by rising global incidence rates, ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...

AstraZeneca is a company with a turbulent history but ... especially in research and development and geographical presence. I am convinced that we will see considerable growth in the years ...

Randomised 1:1 to receive either the placebo of lecanemab 10mg/kg IV biweekly, stratification was according to clinical subgroup (MCI due to AD or mild AD), as well as presence or absence of ...

Presentation Operator Good morning, and welcome to the Interpublic Group 4th-Quarter and Full-Year 2024 Conference Call. All ...

However, the company's... Strategic growth investment ... and entertainment venues engage with their audience Expanded geographic presence and new LATAM leader will bring proven digital signage ...

The new company will focus on supplying, processing, marketing, and distributing cementitious materials (SCM) in global markets. According to executives of the multinational Group, this decision ...

This was the stock's third consecutive day of gains.

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks. In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...